• pulsewidth
    link
    fedilink
    English
    arrow-up
    21
    ·
    2 days ago

    That was discussed in the article, but they also pointed out that in western countries the diagnosis is improving. The bulk of the ‘new cancer’ seems to be in developing nations for multiple reasons.

    However, the data reveals that there are several worlds within the same planet. In wealthy countries, where there has been “success in detection, diagnosis, and treatment,” the authors say, the incidence remains stable and mortality rates are declining (five-year survival rates are between 85% and 90%). In contrast, lower-income regions are experiencing an explosion of new diagnoses, and due to deficiencies in their healthcare systems and limited (or nonexistent) access to top-tier diagnostic and therapeutic resources, mortality rates are also skyrocketing (one study in Africa placed the three-year survival rate at 50%).

    • T156
      link
      fedilink
      English
      arrow-up
      1
      ·
      edit-2
      2 days ago

      Do they account for changing economic factors as well? I would be curious about how many of the new diagnoses are from people who might have died from other causes, or been classified that say.